S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
NYSE:ALC

Alcon Stock Forecast, Price & News

$67.94
+0.88 (+1.31 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$67.05
Now: $67.94
$68.64
50-Day Range
$67.06
MA: $72.48
$76.01
52-Week Range
$39.37
Now: $67.94
$76.26
Volume1.62 million shs
Average Volume1.11 million shs
Market Capitalization$33.17 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.6
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients. It operates through two segments, Surgical and Vision Care. The Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures, such as cataracts, vitreoretinal, refractive laser, and glaucoma surgery. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR ophthalmic microscope, verion imaged guided system, and ORA System for intra-operative measurements and guidance; vitreoretinal products comprising constellation vision system, grieshaber DSP and MIVS instrumentation, ultravit high speed vitrectomy probes, purepoint laser, and NGENUITY 3D visualization system; refractive surgery products, including WaveLight lasers and diagnostics used for LASIK; and glaucoma product, such as EX-PRESS glaucoma filtration device, as well as AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. The Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers under the TOTAL, PRECISION, Dailies, Air Optix, Systane, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Alcon logo

Headlines

Recap: Alcon Q4 Earnings - Yahoo Finance
February 24, 2021 |  finance.yahoo.com
Recap: Alcon Q4 Earnings - Benzinga
February 24, 2021 |  benzinga.com
Recap: Alcon Q4 Earnings
February 24, 2021 |  finance.yahoo.com
Alcon EPS beats by $0.04, beats on revenue - Seeking Alpha
February 23, 2021 |  seekingalpha.com
Alcon Reports Fourth Quarter and Full Year 2020 Results
February 23, 2021 |  finance.yahoo.com
Alcon Q4 2020 Earnings Preview - Seeking Alpha
February 22, 2021 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP04544X30
Phone41-58-911-2000
Employees20,000
Year Founded1945

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.51 billion
Cash Flow$4.75 per share
Book Value$39.54 per share

Profitability

Net Income$-656,000,000.00

Miscellaneous

Market Cap$33.17 billion
Next Earnings Date5/11/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

1.28 out of 5 stars

Medical Sector

807th out of 1,972 stocks

Ophthalmic Goods Industry

5th out of 8 stocks

Analyst Opinion: 1.2Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.9 5 -4 -3 -2 -1 -
$67.94
+0.88 (+1.31 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ALC News and Ratings via Email

Sign-up to receive the latest news and ratings for ALC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Alcon (NYSE:ALC) Frequently Asked Questions

Is Alcon a buy right now?

17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last year. There are currently 2 sell ratings, 7 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Alcon stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALC, but not buy additional shares or sell existing shares.
View analyst ratings for Alcon
or view top-rated stocks.

What stocks does MarketBeat like better than Alcon?

Wall Street analysts have given Alcon a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Alcon wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Alcon?

Alcon saw a decrease in short interest in February. As of February 12th, there was short interest totaling 4,040,000 shares, a decrease of 19.2% from the January 28th total of 5,000,000 shares. Based on an average trading volume of 896,000 shares, the short-interest ratio is currently 4.5 days. Approximately 0.8% of the company's shares are sold short.
View Alcon's Short Interest
.

When is Alcon's next earnings date?

Alcon is scheduled to release its next quarterly earnings announcement on Tuesday, May 11th 2021.
View our earnings forecast for Alcon
.

How were Alcon's earnings last quarter?

Alcon Inc. (NYSE:ALC) issued its earnings results on Monday, February, 22nd. The healthcare company reported $0.41 EPS for the quarter, hitting the Zacks' consensus estimate of $0.41. The healthcare company had revenue of $1.93 billion for the quarter, compared to analysts' expectations of $1.91 billion. Alcon had a positive trailing twelve-month return on equity of 2.80% and a negative net margin of 10.53%. Alcon's revenue was up 2.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.45 earnings per share.
View Alcon's earnings history
.

How has Alcon's stock been impacted by COVID-19?

Alcon's stock was trading at $54.20 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ALC stock has increased by 25.4% and is now trading at $67.94.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for ALC?

17 brokers have issued 12 month target prices for Alcon's shares. Their forecasts range from $50.00 to $86.00. On average, they expect Alcon's share price to reach $65.80 in the next twelve months. This suggests that the stock has a possible downside of 3.1%.
View analysts' price targets for Alcon
or view top-rated stocks among Wall Street analysts.

Who are Alcon's key executives?

Alcon's management team includes the following people:
  • Mr. F. Michael Ball, Exec. Chairman (Age 66, Pay $418.21k)
  • Mr. David J. Endicott, CEO & Director (Age 56, Pay $4.08M)
  • Mr. Arthur B. Cummings M.D., Exec. Director (Age 59, Pay $201.73k)
  • Mr. Timothy C. Stonesifer, Sr. VP & CFO (Age 54)
  • Margaret Buckley, Chief Accounting Officer
  • Ms. Sue-Jean Lin, Sr. VP & Chief Information Officer
  • Ms. Karen King, Sr. VP and Head of Global Investor Relations & Communications
  • Mr. Royce R. Bedward, Sr. VP, Gen. Counsel & Corp. Sec. (Age 55)
  • Mr. Laurent Attias, Sr. VP and Head of Corp. Devel., Strategy, BD&L and M&A (Age 53)
  • Ms. Kimberly Martin, Sr. VP & Chief HR Officer (Age 46)

What is Greg D. Wight's approval rating as Alcon's CEO?

6 employees have rated Alcon CEO Greg D. Wight on Glassdoor.com. Greg D. Wight has an approval rating of 100% among Alcon's employees. This puts Greg D. Wight in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Alcon's key competitors?

What other stocks do shareholders of Alcon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alcon investors own include AT&T (T), Novartis (NVS), Verizon Communications (VZ), International Business Machines (IBM), Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Exxon Mobil (XOM) and AbbVie (ABBV).

What is Alcon's stock symbol?

Alcon trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALC."

Who are Alcon's major shareholders?

Alcon's stock is owned by many different institutional and retail investors. Top institutional investors include Aristotle Capital Management LLC (2.62%), Price T Rowe Associates Inc. MD (2.42%), Norges Bank (2.29%), Schroder Investment Management Group (2.14%), Schroder Investment Management Group (2.14%) and Clearbridge Investments LLC (2.03%).

Which institutional investors are selling Alcon stock?

ALC stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Nuveen Asset Management LLC, Aviva PLC, Sirios Capital Management L P, Primecap Management Co. CA, Lazard Asset Management LLC, Manning & Napier Group LLC, and United Capital Financial Advisers LLC.

Which institutional investors are buying Alcon stock?

ALC stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, Mackenzie Financial Corp, Clearbridge Investments LLC, Fiera Capital Corp, Findlay Park Partners LLP, Alliancebernstein L.P., Schroder Investment Management Group, and Schroder Investment Management Group.

How do I buy shares of Alcon?

Shares of ALC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Alcon's stock price today?

One share of ALC stock can currently be purchased for approximately $67.94.

How much money does Alcon make?

Alcon has a market capitalization of $33.17 billion and generates $7.51 billion in revenue each year. The healthcare company earns $-656,000,000.00 in net income (profit) each year or $1.89 on an earnings per share basis.

How many employees does Alcon have?

Alcon employs 20,000 workers across the globe.

When was Alcon founded?

Alcon was founded in 1945.

What is Alcon's official website?

The official website for Alcon is www.alcon.com.

Where are Alcon's headquarters?

Alcon is headquartered at Rue Louis-d`Affry 6, Fribourg V8, 1701.

How can I contact Alcon?

Alcon's mailing address is Rue Louis-d`Affry 6, Fribourg V8, 1701. The healthcare company can be reached via phone at 41-58-911-2000 or via email at [email protected]


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.